---
url: https://www.servicesaustralia.gov.au/basal-cell-carcinoma-metastatic-or-locally-advanced
title: Basal cell carcinoma - metastatic or locally advanced - Health professionals - Services AustraliaServices AustraliaServices Australia
scrapedAt: 2026-02-20T21:40:07.936Z
source: servicesaustralia.gov.au
---
# Basal cell carcinoma - metastatic or locally advanced

The PBS subsidises sonidegib and vismodegib for patients with metastatic or locally advanced basal cell carcinoma (BCC).

## on this page

-   [Patient eligibility](#a1)
-   [Authority applications](#a2)
-   [More information](#a3)

Please note: Youâ€™ll get an immediate assessment when you request [PBS authorities online](/apply-for-pbs-authority?context=20#accordion1).

## Patient eligibility

The Pharmaceutical Benefits Scheme (PBS) subsidises treatment with sonidegib and vismodegib under the _National Health Act 1953_, section 85 for adult patients with metastatic or locally advanced basal cell carcinoma.

Patients must be eligible for the [PBS](/pharmaceutical-benefits-scheme) and meet the relevant restriction criteria.

The [Schedule of Pharmaceutical Benefits](http://www.pbs.gov.au/pbs/home) on the PBS website outlines the restrictions for prescribing sonidegib and vismodegib.

## Authority applications

### Applying for initial treatment

Applications for initial authority approval to prescribe PBS-subsidised sonidegib or vismodegib to treat metastatic or locally advanced BCC can be made either in:

-   real time using the [Online PBS Authorities system](/apply-for-pbs-authority?context=20)
-   writing and use [HPOS Form upload](/upload-forms-hpos?context=20)
-   writing and mail to [PBS Complex Drugs Programs](/health-professionals-contact-information?context=20#complexdrugs).

All written applications must include:

-   details of the proposed prescription or prescriptions
-   the completed [metastatic or locally advanced basal cell carcinoma - sonidegib or vismodegib - initial authority application form](/pb206?context=20)
-   relevant attachments.

### Applying for continuing treatment

Applications for continuing authority approval to prescribe PBS-subsidised sonidegib or vismodegib to treat metastatic or locally advanced BCC can be made either in:

-   real time using the [Online PBS Authorities system](/apply-for-pbs-authority?context=20)
-   writing and use [HPOS Form upload](/upload-forms-hpos?context=20)
-   writing and mail to [PBS Complex Drugs Programs](/health-professionals-contact-information?context=20#complexdrugs).

All written applications must include:

-   details of the proposed prescription or prescriptions
-   the completed [metastatic or locally advanced basal cell carcinoma - sonidegib or vismodegib - continuing authority application form](/pb207?context=20)
-   relevant attachments.

## More information

Call the [PBS Complex Drugs Programs enquiry line](/health-professionals-contact-information?context=20#complexdrugs) for more information.
